ZNF441 Activators
ZNF441 can influence its function through various signaling pathways that lead to its phosphorylation and activation. Forskolin, by increasing intracellular cAMP levels, activates protein kinase A (PKA), which in turn can phosphorylate ZNF441, enhancing its ability to bind DNA or interact with other transcriptional machinery. Similarly, Dibutyryl-cAMP (db-cAMP), a cAMP analog, activates PKA and may lead to ZNF441 phosphorylation, potentially affecting its transcriptional regulation capabilities. Isoproterenol, another compound that raises intracellular cAMP levels and activates PKA, also contributes to the activation of ZNF441. Alongside these cAMP-related activators, Phorbol 12-myristate 13-acetate (PMA) and its analog 12-O-Tetradecanoylphorbol-13-acetate (TPA) exert their effects via protein kinase C (PKC). PKC activation can lead to phosphorylation events that may facilitate the activation of ZNF441.
Several other chemical activators operate through distinct pathways but converge on the modulation of ZNF441 activity. Ionomycin and A23187, both calcium ionophores, raise intracellular calcium levels and may activate calmodulin-dependent kinase (CaMK), which could phosphorylate ZNF441. Epidermal Growth Factor (EGF) triggers a cascade via the EGF receptor that activates the MAPK/ERK pathway, potentially leading to the phosphorylation of ZNF441. Anisomycin also activates the MAPK/ERK pathway and may similarly influence ZNF441 activity. Insulin stimulates the PI3K/AKT signaling pathway, where AKT phosphorylation can modify various proteins, including those associated with ZNF441 activity. Bryostatin 1, which modulates PKC, could also alter the phosphorylation state of proteins regulating ZNF441, while retinoic acid, through its receptors, may recruit ZNF441 to gene promoters, thereby activating it. Each chemical, through its unique mechanism, contributes to the regulation and activation of ZNF441 by influencing its phosphorylation status or its interaction with DNA and other proteins within the transcriptional machinery.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC). PKC has been shown to phosphorylate various proteins, including transcription factors. PKC-mediated phosphorylation can enhance ZNF441 activation by influencing its DNA-binding affinity or interaction with co-regulators. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase (CaMK), which in turn could phosphorylate ZNF441 or associated regulatory proteins, leading to its activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor and subsequently stimulates the PI3K/AKT signaling pathway. AKT can phosphorylate various downstream effectors, potentially leading to the activation of ZNF441 by promoting its nuclear localization or DNA-binding capacity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that mimics the action of endogenous cAMP. By activating PKA, db-cAMP can lead to phosphorylation of transcription factors, possibly resulting in the activation of ZNF441 through enhanced DNA binding or interaction with transcriptional coactivators. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP levels, thereby activating PKA. PKA-mediated phosphorylation events can lead to the activation of ZNF441 by modifying transcription factor complexes or the chromatin environment. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that raises intracellular calcium levels, similar to ionomycin. The resulting activation of CaMK or other calcium-sensitive pathways could promote the activation of ZNF441 by phosphorylation or alteration of its interaction partners. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to retinoic acid receptors (RARs), which can heterodimerize with retinoid X receptors (RXRs) and regulate gene expression. This interaction may result in the recruitment of ZNF441 to gene promoters, leading to its activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the MAPK/ERK and JNK/SAPK pathways, which could lead to the phosphorylation of transcription factors and co-regulatory proteins involved with ZNF441, thus activating ZNF441's transcriptional activity. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 binds to and modulates PKC activity. This modulation can lead to changes in the phosphorylation state of proteins that regulate ZNF441's function, resulting in its activation and increased transcriptional activity. | ||||||